Peggy Ping Hsu
Peggy Ping Hsu
Verified email at med.umich.edu
Title
Cited by
Cited by
Year
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov, SM Ali, S Sengupta, JH Sheen, PP Hsu, AF Bagley, ...
Molecular cell 22 (2), 159-168, 2006
28402006
Cancer cell metabolism: Warburg and beyond
PP Hsu, DM Sabatini
Cell 134 (5), 703-707, 2008
22242008
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
R Possemato, KM Marks, YD Shaul, ME Pacold, D Kim, K Birsoy, ...
Nature 476 (7360), 346-350, 2011
12112011
The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling
PP Hsu, SA Kang, J Rameseder, Y Zhang, KA Ottina, D Lim, TR Peterson, ...
Science 332 (6035), 1317-1322, 2011
9912011
Tyrosine kinase gene rearrangements in epithelial malignancies
AT Shaw, PP Hsu, MM Awad, JA Engelman
Nature reviews Cancer 13 (11), 772-787, 2013
2602013
A genome-wide visual screen reveals a role for sphingolipids and ergosterol in cell surface delivery in yeast
TJ Proszynski, RW Klemm, M Gravert, PP Hsu, Y Gloor, J Wagner, ...
Proceedings of the National Academy of Sciences 102 (50), 17981-17986, 2005
1442005
Nucleocytoplasmic shuttling of the Golgi phosphatidylinositol 4-kinase Pik1 is regulated by 14-3-3 proteins and coordinates Golgi function with cell growth
L Demmel, M Beck, C Klose, AL Schlaitz, Y Gloor, PP Hsu, J Havlis, ...
Molecular biology of the cell 19 (3), 1046-1061, 2008
702008
Genome-scale RNAi on living-cell microarrays identifies novel regulators of Drosophila melanogaster TORC1–S6K pathway signaling
RA Lindquist, KA Ottina, DB Wheeler, PP Hsu, CC Thoreen, DA Guertin, ...
Genome research 21 (3), 433-446, 2011
432011
Identification of DHODH as a therapeutic target in small cell lung cancer
L Li, SR Ng, CI Colón, BJ Drapkin, PP Hsu, Z Li, CS Nabel, CA Lewis, ...
Science translational medicine 11 (517), 2019
242019
Lung cancer: a wily genetic opponent
PP Hsu, AT Shaw
Cell 169 (5), 777-779, 2017
132017
Induction of a timed metabolic collapse to overcome cancer chemoresistance
N van Gastel, JB Spinelli, A Sharda, A Schajnovitz, N Baryawno, C Rhee, ...
Cell Metabolism 32 (3), 391-403. e6, 2020
92020
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
R Romero, FJ Sánchez-Rivera, PMK Westcott, KL Mercer, A Bhutkar, ...
Nature Cancer 1 (6), 589-602, 2020
52020
DHODH inhibitors in the treatment of acute myeloid leukemia: Defining the mechanism of action and the basis of the metabolic therapeutic window
PP Hsu, Y Kfoury, N Aziz, J Elkhoury, B Hallgren, DT Scadden, ...
Blood 132 (Supplement 1), 2716-2716, 2018
22018
Publisher Correction: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
R Romero, FJ Sánchez-Rivera, PMK Westcott, KL Mercer, A Bhutkar, ...
Nature Cancer 1 (9), 935-935, 2020
2020
Archive for the ‘Amino acids’ Category
PP Hsu, DM Sabatini
Cell 134, 703-707, 2008
2008
The system can't perform the operation now. Try again later.
Articles 1–15